Leap Therapeutics announced it will rebrand to Cypherpunk Technologies and allocate $50 million to acquire Zcash (ZEC) for its corporate treasury, along with a leadership overhaul to execute the pivot.
Leap Therapeutics has rebranded to Cypherpunk Technologies as it pivots from oncology to a digital treasury, following a $58.9M funding round led by Winklevoss Capital and a roughly $50M allocation to Zcash (ZEC).
Zcash (ZEC) plunged roughly 33% over 48 hours following the launch of the network's first ZEC DAT campaign, coinciding with Nasdaq-listed Leap Therapeutic raising $58.9M and rebranding to Cypherpunk Technologies to back ZEC. The moves have amplified market volatility and raised fresh adoption and regulatory questions.
Leap Therapeutics announced a rebrand to Cypherpunk Technologies Inc. and purchased 203,775 Zcash (ZEC) for its corporate treasury, saying the move is backed by a Winklevoss investment. The company says it will merge its biotech operations with a new digital-assets strategy.
Leap Therapeutics has changed its name to Cypherpunk Technologies Inc., signaling a strategic pivot to support Zcash (ZEC) and privacy-focused blockchain work. The rebrand points to renewed corporate attention on development, infrastructure, and services tied to Zcash.